BioSpace News Archive

FDA

FDA Action Alert: Regeneron and Sanofi have a Busy Week, Plus Heron and Nabriva

This week has a number of approvals expected by the U.S. Food and Drug Administration. Let’s take a look.

April 26, 2019
·
4 min read
·
Mark Terry
Auris Medical Provides Update on Tinnitus Drug Development Strategy

Auris Medical Holding Ltd. provided an update on its tinnitus drug development strategy.

April 26, 2019
·
6 min read
Bio NC

Almac Group Launches TempEZ™ Site Storage Temperature Compliance Module

A truly end-to-end regulatory compliant clinical supply chain solution.

April 26, 2019
·
3 min read
Business

J. David Warren, Ph.D., Joins Scientific Advisory Board of Akelos Inc., Biotechnology Company Developing Opioid Alternatives

Akelos Inc., a biotechnology company currently developing and commercializing a novel, non-opioid anti-hyperalgesic drug to treat chronic and neuropathic pain, adds J. David Warren, Ph.D., to its Scientific Advisory Board.

April 26, 2019
·
4 min read
Deals

Roche’s Spark Buyout Delayed … Again

This is the second extension that has been filed, this time delaying it until June 3. The companies indicate it is because U.S. authorities are taking longer than expected to review the deal.

April 26, 2019
·
2 min read
·
Mark Terry
Business

Immunicum AB (publ) Interim Report January - March 2019

Preparations for Upcoming Clinical Data in the MERECA and GIST Studies and First Patient Treated in the ILIAD Study

April 26, 2019
·
4 min read
Business

GeoVax Recognizes World Malaria Day 2019

Bringing Attention to Malaria Vaccine Development Efforts

April 26, 2019
·
5 min read
Business

Aqilion initiates collaboration with Immunscape

Aqilion searches for early innovative pharmaceutical projects that are based on solid research resting on a firm biological foundation and offering both clinical relevance and patient benefit.

April 26, 2019
·
2 min read
BioForest

Poll Takers Place Opioid Crisis Blame at the Feet of the Pharmaceutical Industry

A new poll shows nearly two-thirds of people blame the pharmaceutical companies for the opioid crisis.

April 26, 2019
·
3 min read
·
Alex Keown
Policy

Amgen, Astellas Fork Over Nearly $125 Million to Settle Medicare Kickback Claims

The federal anti-kickback statute prevents pharmaceutical companies from providing financial coverage of Medicare copay payments that would encourage patients to purchase a company’s medication.

April 26, 2019
·
3 min read
·
Alex Keown